SUDARSHAN logo

Sudarshan Pharma Industries Ltd

SUDARSHAN·BSE·
₹35.00▼ -1.40 (-3.85%)
Market Cap873.81 Cr
PE Ratio36.08
Volume1,04,000
Day High - Low35.60 - 34.59
52W High-Low42.79 - 18.50

Sudarshan Pharma Industries Ltd (SUDARSHAN): company summary

The company's annual revenue rose 39.2% to ₹703 crore, while annual net profit increased 47.2% to ₹23 crore.

Sudarshan Pharma Industries Ltd (SUDARSHAN) is a micro-cap Commodities company valued at ₹874 crore operating in Chemicals & Petrochemicals on the NSE and BSE.

Recent price move
Sudarshan Pharma Industries Ltd last traded at ₹35, down 3.85% on the day.
Financial performance
The company's annual revenue rose 39.2% to ₹703 crore, while annual net profit increased 47.2% to ₹23 crore. The latest quarter saw revenue rise 20.1% to ₹174 crore and net profit jump 41.7% to ₹6 crore compared to the same quarter a year earlier.
Valuation multiples
The stock trades at 36.1 times earnings, a premium to the Commodities median of 20.9, 5.72 times book value. It yields 0.8%.
Things to watch
The company has a high debt to equity ratio of 1.84. The stock is 14.9% below its 52-week high. Net profit margin increased 0.2 percentage points to 3.3%.
Where it stands
The company's business has improved with strong revenue and profit growth over the past year and quarter. The most significant movement was in net profit, which rose 47.2% annually and 41.7% in the latest quarter. The stock is 14.9% below its 52-week high.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
5.3/10
Weak
Fair Value
Sign in to see
ROE
15.03%
Strong
P/E
36.08x
Expensive
Debt / Equity
1.84
High
Industry
Commodities
Chemicals & Petrochemicals
Overall View
Mixed

Price performance

Day₹34.59
₹35.60
52W₹18.50
₹42.79
DocStoX take

Supported by growth (10.0) and momentum (7.5), but held back by valuation (1.4). Growth looks strong at 10.0, but that is offset by valuation at 1.4. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.3
/10
Weak
Quality
Modest
ROE 15.0%
Valuation
Expensive
P/E 36.1×
Growth
Strong
Revenue +29.5% 5Y CAGR
Risk
Moderate
D/E 1.84
Momentum
Strong
68% of 52-week range

At a glance

Market Cap
₹874 Cr
52W High / Low
₹43 / ₹19
Dividend Yield
0.77%
Promoter Holding
58.93%
EPS (TTM)
₹0.97
Book Value
₹6.44

Key highlights

  • Profit compounding 51% a year
  • Revenue compounding 30% a year
  • Profitable in all of the last 5 years
  • High leverage — debt is 1.8× equity
  • Valuation is weak (1.4/10)
3 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Commodities stocks · Chemicals & Petrochemicals

Sudarshan Pharma Industries Ltd peers in Commodities

Other Commodities stocks on the NSE & BSE. See the full Commodities sector list.